Arash Hossein-Nezhad, MD, PhD
Research Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Endocrinology, Diabetes, Nutrition & Weight Management

MD/PhD, Tehran University



Dr. Arash Hossein-nezhad, MD, PhD is a Research Assistant Professor of Endocrinology, Diabetes & Nutrition at Boston University. Dr. Hossein-nezhad is a multidisciplinary scientist with a background in human and molecular genetics, nutrition, endocrinology, cancer, immunology and bioinformatics focused on epigenetic researches. He has extensive experience in research with over 100 peer reviewed publications as well as experience in other research and clinical areas such as bone clinic, microarray and CGH array, liquid chromatography tandem mass spectroscopy, real time PCR, circulating miRNA and microvesicles, Elisa, stem cells and tissue engineering, and next generation sequencing.


QR-TRP-039 - Evaluation of the Solius Device in the Increase in Vitamin D Levels in Subjects With Vitamin D Insufficiency or Deficiency
05/17/2021 - 11/30/2024 (Multi-PI)
PI: Arash Hossein-Nezhad, MD, PhD
Solius


Pilot clinical trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults and adults with a history of intestinal malabsorption
11/26/2018 - 11/26/2020 (Co-Investigator)
PI: Michael F. Holick, MD, PhD
CARBOGEN AMCIS AG




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Shirvani A, Holick MF. Effectiveness of SOLIUS UVB Light System in Enhancing Serum 25-Hydroxyvitamin D Concentrations: A Randomized Controlled Trial. Anticancer Res. 2025 Aug; 45(8):3327-3339.View Related Profiles. PMID: 40750396
     
  2. Shirvani P, Shirvani A, Holick MF. Mitochondrial Dysfunction and Its Potential Molecular Interplay in Hypermobile Ehlers-Danlos Syndrome: A Scoping Review Bridging Cellular Energetics and Genetic Pathways. Curr Issues Mol Biol. 2025 Feb 19; 47(2).View Related Profiles. PMID: 39996855; PMCID: PMC11854588; DOI: 10.3390/cimb47020134;
     
  3. Shirvani A, Shirvani P, Jonah U, Moore BE, Holick MF. Suspected Mitochondrial Dysfunction and Complex Pathophysiology in Fatal Hypermobile Ehlers-Danlos Syndrome: Insights from a Case Report and Post-Mortem Findings. Biomedicines. 2025 Feb 14; 13(2).View Related Profiles. PMID: 40002882; PMCID: PMC11852713; DOI: 10.3390/biomedicines13020469;
     
  4. Shirvani P, Shirvani A, Holick MF. Decoding the Genetic Basis of Mast Cell Hypersensitivity and Infection Risk in Hypermobile Ehlers-Danlos Syndrome. Curr Issues Mol Biol. 2024 Oct 17; 46(10):11613-11629.View Related Profiles. PMID: 39451569; PMCID: PMC11506785; DOI: 10.3390/cimb46100689;
     
  5. Maghbooli Z, Shirvani A, Moghadasi AN, Varzandi T, Hamtaei Ghashti S, Sahraian MA. Investigating the effects of 25-hydroxyvitamin D3 on clinical outcomes in multiple sclerosis patients: A randomized, double-blind clinical trial- a pilot study. Mult Scler Relat Disord. 2024 Jul; 87:105673. PMID: 38759424; DOI: 10.1016/j.msard.2024.105673;
     
  6. Rafiee S, Hossein-Nezhad A, Maghbooli Z, Zargaran A, Emamgholipour S, Ghasemi A, Ahmadi M, Esmaeeli H, Karimi M. Effect of Padzahr Tablet on Biochemical Indices of Bone Remodeling in Postmenopausal Females with Osteopenia: A Randomized Double-Blind Placebo-Controlled Trial. Galen Med J. 2024; 13:1-10. PMID: 39554395; PMCID: PMC11568423; DOI: 10.31661/gmj.v12i.2950;
     
  7. Charoenngam N, Nasr A, Shirvani A, Holick MF. Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management. Genes (Basel). 2022 Oct 17; 13(10).View Related Profiles. PMID: 36292765; PMCID: PMC9601711; DOI: 10.3390/genes13101880;
     
  8. Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, Asadi A, Zarei A, Zendehdel A, Varzandi T, Mohammadnabi S, Alijani N, Karimi M, Shirvani A, Holick MF. Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial. Endocr Pract. 2021 Dec; 27(12):1242-1251.View Related Profiles. PMID: 34653608; PMCID: PMC8511889; DOI: 10.1016/j.eprac.2021.09.016;
     
  9. Charoenngam N, Kalajian TA, Shirvani A, Yoon GH, Desai S, McCarthy A, Apovian CM, Holick MF. A pilot-randomized, double-blind crossover trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults with differing BMI and in adults with intestinal malabsorption. Am J Clin Nutr. 2021 09 01; 114(3):1189-1199.View Related Profiles. PMID: 34008842; PMCID: PMC8408845; DOI: 10.1093/ajcn/nqab123;
     
  10. Charoenngam N, Kalajian TA, Shirvani A, Yoon GH, Desai S, McCarthy A, Apovian CM, Holick MF. Reply to S Minisola et al. Am J Clin Nutr. 2021 09 01; 114(3):1252-1253.View Related Profiles. PMID: 34467971
     
Showing 10 of 109 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 109 publications over 22 distinct years, with a maximum of 11 publications in 2013

YearPublications
20031
20042
20052
20064
20075
20082
20093
20107
20117
20129
201311
20146
20155
20168
20176
20183
20197
20207
20217
20221
20243
20253

Contact for Mentoring:

75 E. Newton St
Boston MA 02118
Google Map


Hossein-Nezhad's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department